Cyclin A1 is a protein that belongs to the cyclin family and plays an essential role in cell cycle regulation. Specifically, it is critical for the progression from the G1 phase to the S phase and from the G2 phase to the M phase of the cell cycle. Cyclin A1 forms a complex with cyclin-dependent kinases (CDKs), primarily CDK2, thereby activating these kinases to phosphorylate target proteins. This phosphorylation then drives the cell cycle forward by promoting DNA replication and mitosis. Given the pivotal role cyclin A1 plays in cell cycle progression, it is tightly regulated at various levels, including transcription, translation, and degradation.
The chemical class of Cyclin A1 Activators is focused on compounds that can influence the expression or activity of cyclin A1. Such activators work by modulating intracellular signaling pathways that, in turn, impact cyclin A1 levels or its ability to form complexes with CDKs. Some chemicals, like specific phosphatase inhibitors, can enhance cyclin A1 levels by inhibiting its degradation, thus prolonging its active state within the cell. Others, such as certain kinase activators, may bolster the formation of the cyclin A1-CDK complex, consequently enhancing its kinase activity and promoting cell cycle progression. Additionally, small molecules that target transcription factors can influence the transcriptional activity of the cyclin A1 gene. These activators don't directly bind to cyclin A1; rather, they exert their effects by acting on various upstream elements in signaling pathways that culminate in the activation of cyclin A1. Overall, Cyclin A1 Activators represent a diverse set of chemicals that offer valuable tools for studying the complex regulation of the cell cycle.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, can upregulate cyclin A1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Can induce differentiation and increase cyclin A1 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates Akt pathway which can subsequently affect cyclin A1. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK3β, which in turn can lead to cyclin A1 stabilization. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor, affecting Akt pathway and potentially cyclin A1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, affecting downstream targets including cyclin A1. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Protein kinase inhibitor that can affect cyclin A1 indirectly. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, leading to cell cycle arrest, affecting cyclin A1. | ||||||